About Centrul de Oncologie Euroclinic
Clinical Trials at Centrul de Oncologie Euroclinic
During the past decade, Centrul de Oncologie Euroclinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrul de Oncologie Euroclinic" #1 sponsor was "BeiGene" with 1 trials, followed by "Helsinn Healthcare SA" with 1 trials
sponsored, "Samsung Bioepis Co., Ltd." with 1 trials sponsored, "Sumitomo Pharma Oncology, Inc." with 1 trials sponsored and "Takeda"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrul de Oncologie Euroclinic"
#1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrul de Oncologie Euroclinic
According to Clinical.Site data, the most researched conditions in "Centrul de Oncologie Euroclinic" are
"ALK+ Advanced NSCLC" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Cancer" (1 trials). Many other conditions were trialed in "Centrul de Oncologie Euroclinic" in a lesser frequency.
Clinical Trials Intervention Types at Centrul de Oncologie Euroclinic
Most popular intervention types in "Centrul de Oncologie Euroclinic" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "Placebo" (2 trials), "Alectinib" (1 trials), "BBI608" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrul de Oncologie Euroclinic
The vast majority of trials in "Centrul de Oncologie Euroclinic" are
5 trials for "All" genders.
Clinical Trials Status at Centrul de Oncologie Euroclinic
Currently, there are NaN active trials in "Centrul de Oncologie Euroclinic".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centrul de Oncologie Euroclinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrul de Oncologie Euroclinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".